A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas

Authors

Keywords

Journal

Volume 26, Issue 4, Pages 369-379

Publisher

Springer Nature

Online

2008-02-16

DOI

10.1007/s10637-008-9123-6

Explore over 38,000 international journals covering a vast array of academic fields.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started